Summary

The global diagnostic contract manufacturing market is projected to reach USD 44.9 Billion by 2028 from USD 26.0 Billion in 2023, at a CAGR of 11.5% during the forecast period. The growth of this market is majorly driven by the growth in the adoption of robotics and automation in manufacturing processes. However, the increasing adoption of refurbished diagnostic imaging systems challenges the growth of the diagnostic contract manufacturing market.
“The diagnostic imaging devices segment accounted for the highest growth rate in the diagnostic contract manufacturing market, by device, during the forecast period.”
Based on the type segment, the diagnostic contract manufacturing market is segmented into In vitro diagnostic devices, diagnostic imaging devices, and other devices. Diagnostic imaging devices include CT, X-ray, MRI, Ultrasound, and other imaging devices. Due to rapid economic growth, the adoption of these devices is expected to increase in developing countries in the coming years.
“Orthopedics application segment accounted for the highest CAGR during the forecast period among diagnostic imaging devices application.”
Based on application, the diagnostic imaging devices market is segmented into cardiology, neurology, orthopedics, oncology, and others. In 2022, cardiology dominated the market, and orthopedics observed the highest growth rate. Factors supporting the growth of orthopedics applications are the rising geriatric population and the growing prevalence of orthopedic diseases and disorders.
“The Asia Pacific segment accounted for the highest growth rate in the diagnostic contract manufacturing systems market, by region, during the forecast period.”
Based on the region, the global diagnostic contract manufacturing market is categorized into North America, Europe, Asia Pacific, and Rest of the World. Asia Pacific is expected to witness a high growth rate during the forecast period. Low labor costs and rapidly changing healthcare infrastructure hold massive potential for the Asia Pacific diagnostic contract manufacturing market.
Breakdown of supply-side primary interviews by company type, designation, and region:
• By Company Type: Tier 1- 55%, Tier 2- 40%, and Tier 3- 5%
• By Designation: C-level - 37%, Director-level - 48%, and Others-15%
• By Region: North America- 56%, Europe -17%, Asia- Pacific -20%, and Rest of the World -7%
Prominent companies include Jabil Inc. (US), Flex Ltd. (Singapore), Plexus Corp. (US), Sanmina Corporation (US), TE Connectivity Ltd. (Switzerland), Celestica Inc. (Canada), Integer Holdings Corporation (US), Nipro Corporation (Japan), Thermo Fisher Scientific (US), West Pharmaceutical Services Inc. (US), Benchmark Electronics Inc. (US), Kimball Electronics Inc. (US), KMS Systems (US), Savyon Diagnostics (Israel), Nova Biomedical (US), Cenogenics Corporation (US), Cone Bioproducts (US), Avioq, Inc. (US), Philips-Medisize Corporation (US), Invetech (Australia), Meridian Bioscience, Inc. (US), Nolato AB (Sweden), Fujirebio (Japan), Sekisui (US), Prestige Diagnostics (UK), and Biokit (Spain).

Research Coverage
This research report categorizes the diagnostic contract manufacturing market by device (In Vitro Diagnostic Devices, Diagnostic Imaging Devices, Other Devices), services (Device Development and Manufacturing Services, Quality Management Services, Packaging and Assembly Services, and Other Services), end-user (In Vitro Diagnostic Devices (Infectious Diseases, Oncology, Cardiology, Others), Diagnostic Imaging Devices (Cardiology, Oncology, Orthopedics, Neurology, Others), Other Devices (Gastroenterology, Gynecology, Others), and region (North America, Europe, Asia Pacific, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the diagnostic contract manufacturing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the diagnostic contract manufacturing market. Competitive analysis of upcoming startups in the diagnostic contract manufacturing market ecosystem is covered in this report.

Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall diagnostic contract manufacturing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
• Analysis of key drivers (early diagnosis and widening scope of clinical applications, adoption of robotics and automation in manufacturing processes, growing outsourcing activity by IVD manufacturers, and high cost of in-house IVD manufacturing), restraints (IP protection concerns and possibility of theft), opportunities (growth opportunities in emerging economies), and challenges (Increasing adoption of refurbished diagnostic imaging systems, lack of constant innovation to balance technological capabilities against costs, and shortage of skilled labor).
• Market Development: Comprehensive information about lucrative markets – the report analyses the diagnostic contract manufacturing market across varied regions.
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the diagnostic contract manufacturing market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Jabil Inc. (US), Flex Ltd. (Singapore), Plexus Corp. (US), Sanmina Corporation (US), TE Connectivity Ltd. (Switzerland), Celestica Inc. (Canada), among others in the diagnostic contract manufacturing market strategies.

ページTOPに戻る

Table of Contents

1 INTRODUCTION 30
1.1 STUDY OBJECTIVES 30
1.2 MARKET DEFINITION 30
TABLE 1 INCLUSIONS AND EXCLUSIONS 31
1.3 STUDY SCOPE 32
FIGURE 1 DIAGNOSTIC CONTRACT MANUFACTURING MARKET SEGMENTATION 32
1.3.1 YEARS CONSIDERED 33
1.4 CURRENCY CONSIDERED 33
1.5 STAKEHOLDERS 33
2 RESEARCH METHODOLOGY 34
2.1 RESEARCH DATA 34
FIGURE 2 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: RESEARCH DESIGN METHODOLOGY 34
2.1.1 SECONDARY DATA 35
2.1.1.1 Key data from secondary sources 36
2.1.2 PRIMARY DATA 37
FIGURE 3 PRIMARY SOURCES 37
2.1.3 KEY INDUSTRY INSIGHTS 38
2.1.3.1 Key data from primary sources 38
2.1.3.2 Breakdown of primary interviews 39
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 39
2.2 MARKET SIZE ESTIMATION 39
2.2.1 BOTTOM-UP APPROACH 39
2.2.1.1 Approach 1: Company revenue estimation approach 40
FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 40
2.2.1.2 Approach 2: Presentations of companies and primary interviews 40
2.2.1.3 Approach 3: COGS approach 40
FIGURE 6 DEMAND-SIDE ESTIMATION FOR DIAGNOSTIC CONTRACT MANUFACTURING MARKET 41
2.2.1.4 Approach 4: Parent market approach (in-house vs. outsourcing market) 41
2.2.1.5 Growth forecast 42
2.2.1.6 CAGR projections 42
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 42
2.2.2 TOP-DOWN APPROACH 42
FIGURE 8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: TOP-DOWN APPROACH 42

2.3 DATA TRIANGULATION 44
FIGURE 9 DATA TRIANGULATION METHODOLOGY 44
2.4 STUDY ASSUMPTIONS 45
2.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT 45
TABLE 2 RISK ASSESSMENT: DIAGNOSTIC CONTRACT MANUFACTURING MARKET 46
3 EXECUTIVE SUMMARY 47
FIGURE 10 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2023 VS. 2028 (USD MILLION) 47
FIGURE 11 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2023 VS. 2028 (USD MILLION) 48
FIGURE 12 IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 48
FIGURE 13 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2023 VS. 2028 (USD MILLION) 49
4 PREMIUM INSIGHTS 50
4.1 DIAGNOSTIC CONTRACT MANUFACTURING MARKET OVERVIEW 50
FIGURE 14 HIGH COST OF IN-HOUSE MANUFACTURING TO DRIVE DEMAND FOR DIAGNOSTIC CONTRACT MANUFACTURING 50
4.2 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION (2023–2028) 51
FIGURE 15 ASIA PACIFIC MARKET TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 51
4.3 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE AND COUNTRY (2022) 52
FIGURE 16 IVD DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET IN 2022 52
4.4 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 53
FIGURE 17 MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
FIGURE 18 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 54
5.2.1 DRIVERS 55
5.2.1.1 Increasing demand for early diagnosis and widening scope of clinical applications 55
5.2.1.2 Adoption of robotics and automation in manufacturing processes 55
5.2.1.3 Growing outsourcing activity by IVD manufacturers 56
5.2.1.4 High cost of in-house IVD manufacturing 56
5.2.2 RESTRAINTS 57
5.2.2.1 IP protection concerns and possibility of IP theft 57
5.2.3 OPPORTUNITIES 57
5.2.3.1 Growth opportunities in emerging economies 57
5.2.4 CHALLENGES 57
5.2.4.1 Increasing adoption of refurbished diagnostic imaging systems 57
5.2.4.2 Lack of constant innovation to balance technological capabilities against costs 58
5.2.4.3 Shortage of skilled labor 58
5.3 SUPPLY CHAIN ANALYSIS 58
FIGURE 19 DIAGNOSTIC CONTRACT MANUFACTURING: SUPPLY CHAIN 59
5.4 PORTER’S FIVE FORCES ANALYSIS 59
5.4.1 THREAT OF NEW ENTRANTS 59
5.4.2 THREAT OF SUBSTITUTES 60
5.4.3 BARGAINING POWER OF SUPPLIERS 60
5.4.4 BARGAINING POWER OF BUYERS 60
5.4.5 INTENSITY OF COMPETITIVE RIVALRY 61
5.5 ECOSYSTEM ANALYSIS 61
FIGURE 20 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: ECOSYSTEM ANALYSIS 61
5.5.1 ROLE IN ECOSYSTEM 62
FIGURE 21 KEY PLAYERS IN DIAGNOSTIC CONTRACT MANUFACTURING MARKET ECOSYSTEM 62
5.6 REGULATORY ANALYSIS 63
TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING DIAGNOSTIC CONTRACT MANUFACTURING 63
5.6.1 NORTH AMERICA 64
5.6.1.1 US 64
TABLE 4 US: CLASSIFICATION OF MEDICAL EQUIPMENT 64
5.6.1.2 Canada 64
5.6.2 EUROPE 65
5.6.3 ASIA PACIFIC 65
5.6.3.1 Japan 65
TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 66
TABLE 6 JAPAN: CLASSIFICATION OF IVD REAGENTS 66
5.6.3.2 China 66
TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES 67
5.6.3.3 India 68
5.7 KEY CONFERENCES AND EVENTS IN 2022–2023 68
TABLE 8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2022–2023 68
5.8 TECHNOLOGY ANALYSIS 70
6 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE 71
6.1 INTRODUCTION 72
TABLE 9 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 72

6.2 IN VITRO DIAGNOSTIC DEVICES 72
TABLE 10 IN VITRO DIAGNOSTIC DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 72
TABLE 11 IN VITRO DIAGNOSTIC DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 73
6.2.1 IVD CONSUMABLES 73
6.2.1.1 Consumables segment to dominate IVD contract manufacturing market 73
TABLE 12 IVD CONSUMABLES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 74
6.2.2 IVD EQUIPMENT 74
6.2.2.1 Automation, advancements, and emphasis on efficient diagnostics to drive growth 74
TABLE 13 IVD EQUIPMENT: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 74
6.3 DIAGNOSTIC IMAGING DEVICES 75
TABLE 14 DIAGNOSTIC IMAGING DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 75
TABLE 15 DIAGNOSTIC IMAGING DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 76
6.3.1 CT 76
6.3.1.1 Rising adoption of CT scanners for detection of tumors to support growth 76
TABLE 16 CT: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 77
6.3.2 ULTRASOUND 77
6.3.2.1 Minimally invasive nature of ultrasound to boost demand 77
TABLE 17 ULTRASOUND: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 78
6.3.3 X-RAY 78
6.3.3.1 Low cost of X-ray imaging compared to other modalities to drive growth 78
TABLE 18 X-RAY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 79
6.3.4 MRI 79
6.3.4.1 Innovation and advancement in MRI applications to drive demand 79
TABLE 19 MRI: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 80
6.3.5 OTHER DIAGNOSTIC IMAGING DEVICES 80
TABLE 20 OTHER DIAGNOSTIC IMAGING DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 81
6.4 OTHER DEVICES 81
TABLE 21 OTHER DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 82

7 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE 83
7.1 INTRODUCTION 84
TABLE 22 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 84
7.2 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES 84
7.2.1 DEVICE MANUFACTURING SERVICES TO WITNESS HIGH GROWTH DURING FORECAST PERIOD 84
TABLE 23 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 85
7.3 QUALITY MANAGEMENT SERVICES 85
7.3.1 STRINGENT REGULATIONS AND INCREASING PRODUCT SAFETY CONCERNS TO DRIVE DEMAND FOR QUALITY MANAGEMENT SERVICES 85
TABLE 24 QUALITY MANAGEMENT SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 86
7.4 PACKAGING AND ASSEMBLY SERVICES 86
7.4.1 INCREASING PRODUCT SAFETY CONCERNS FOR MEDICAL DEVICES TO SUPPORT GROWTH 86
TABLE 25 PACKAGING AND ASSEMBLY SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 86
7.5 OTHER SERVICES 87
TABLE 26 OTHER SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 87
8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY APPLICATION 88
8.1 INTRODUCTION 89
8.2 IN VITRO DIAGNOSTIC DEVICE APPLICATIONS 89
TABLE 27 IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 89
8.2.1 INFECTIOUS DISEASES 89
8.2.1.1 Increasing incidence of infectious diseases to drive adoption of IVD devices 89
TABLE 28 INFECTIOUS DISEASES: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 90
8.2.2 DIABETES 90
8.2.2.1 Rising prevalence of diabetes to drive adoption of glucose monitoring devices 90
TABLE 29 DIABETES: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 91
8.2.3 ONCOLOGY 91
8.2.3.1 Rising initiatives for early detection of cancer to drive growth 91
TABLE 30 ONCOLOGY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 91

8.2.4 CARDIOLOGY 92
8.2.4.1 Increasing use of immunoassays in detection of CVD to drive growth 92
TABLE 31 CARDIOLOGY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 92
8.2.5 OTHER APPLICATIONS (IVD DEVICES) 92
TABLE 32 OTHER APPLICATIONS: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 93
8.3 DIAGNOSTIC IMAGING DEVICE APPLICATIONS 93
TABLE 33 DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 93
8.3.1 CARDIOLOGY 94
8.3.1.1 High prevalence of CVD to drive growth 94
TABLE 34 CARDIOLOGY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 94
8.3.2 ONCOLOGY 94
8.3.2.1 Wide adoption of nuclear imaging systems to distinguish between benign and malignant tumors to drive growth 94
TABLE 35 ONCOLOGY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 95
8.3.3 ORTHOPEDICS 95
8.3.3.1 Effective diagnosis and prognosis of musculoskeletal disorders by imaging devices to drive growth 95
TABLE 36 ORTHOPEDICS: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 95
8.3.4 NEUROLOGY 96
8.3.4.1 Innovations in 3D MRI technology to drive growth 96
TABLE 37 NEUROLOGY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 96
8.3.5 OTHER APPLICATIONS (DIAGNOSTIC IMAGING DEVICES) 96
TABLE 38 OTHER APPLICATIONS: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 97
8.4 OTHER DEVICE APPLICATIONS 97
TABLE 39 OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 97
8.4.1 GASTROENTEROLOGY 98
8.4.1.1 Surging demand for early diagnosis to propel growth 98
TABLE 40 ESTIMATED NEW GI CANCER CASES AND DEATHS IN US, 2021 98
TABLE 41 GASTROENTEROLOGY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 98
8.4.2 GYNECOLOGY 99
8.4.2.1 Rising cases of cancer among women to drive growth 99
TABLE 42 GYNECOLOGY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 99
8.4.3 OTHER APPLICATIONS (OTHER DEVICES) 99
TABLE 43 OTHER APPLICATIONS: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 100
9 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION 101
9.1 INTRODUCTION 102
TABLE 44 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021–2028 (USD MILLION) 102
9.2 ASIA PACIFIC 102
9.2.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION 102
FIGURE 22 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET SNAPSHOT 103
TABLE 45 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 104
TABLE 46 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 104
TABLE 47 ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 104
TABLE 48 ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 105
TABLE 49 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 105
TABLE 50 ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 106
TABLE 51 ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 106
TABLE 52 ASIA PACIFIC: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 107
9.2.2 CHINA 107
9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive growth 107
TABLE 53 CHINA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 107
TABLE 54 CHINA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 55 CHINA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 108
TABLE 56 CHINA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 109
TABLE 57 CHINA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 109
TABLE 58 CHINA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 110
TABLE 59 CHINA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 110
9.2.3 JAPAN 110
9.2.3.1 Need for advanced medical diagnostic tools to fuel growth 110
TABLE 60 JAPAN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 111
TABLE 61 JAPAN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 62 JAPAN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 111
TABLE 63 JAPAN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 112
TABLE 64 JAPAN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 112
TABLE 65 JAPAN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 113
TABLE 66 JAPAN: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 113
9.2.4 INDIA 113
9.2.4.1 Rising contract manufacturing capabilities to support growth 113
TABLE 67 INDIA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 114
TABLE 68 INDIA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
TABLE 69 INDIA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 114
TABLE 70 INDIA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 115
TABLE 71 INDIA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 115
TABLE 72 INDIA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 116
TABLE 73 INDIA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 116
9.2.5 REST OF ASIA PACIFIC 116
TABLE 74 REST OF ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 117
TABLE 75 REST OF ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 117
TABLE 76 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 117
TABLE 77 REST OF ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 118
TABLE 78 REST OF ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 118
TABLE 79 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 119
TABLE 80 REST OF ASIA PACIFIC: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 119
9.3 NORTH AMERICA 119
9.3.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION 119
FIGURE 23 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET SNAPSHOT 120
TABLE 81 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 121
TABLE 82 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 121
TABLE 83 NORTH AMERICA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 121
TABLE 84 NORTH AMERICA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 122
TABLE 85 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 122
TABLE 86 NORTH AMERICA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 123
TABLE 87 NORTH AMERICA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 123
TABLE 88 NORTH AMERICA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 124
9.3.2 US 124
9.3.2.1 Rising in-house manufacturing costs to drive shift toward contract manufacturing 124
TABLE 89 US: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 124
TABLE 90 US: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 91 US: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 125
TABLE 92 US: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 126
TABLE 93 US: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 126
TABLE 94 US: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 127
TABLE 95 US: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 127
9.3.3 CANADA 127
9.3.3.1 Strong presence of key manufacturing companies to augment market 127
TABLE 96 CANADA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 128
TABLE 97 CANADA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 128
TABLE 98 CANADA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 129
TABLE 99 CANADA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 129
TABLE 100 CANADA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 130
TABLE 101 CANADA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 130
TABLE 102 CANADA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 131
9.4 EUROPE 131
9.4.1 EUROPE: IMPACT OF ECONOMIC RECESSION 131
TABLE 103 EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 132
TABLE 104 EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 132
TABLE 105 EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 106 EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 133
TABLE 107 EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 134
TABLE 108 EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 134
TABLE 109 EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 135
TABLE 110 EUROPE: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 135
9.4.2 GERMANY 135
9.4.2.1 Germany to hold largest market share in Europe 135
TABLE 111 GERMANY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 136
TABLE 112 GERMANY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 136
TABLE 113 GERMANY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 137
TABLE 114 GERMANY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 137
TABLE 115 GERMANY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 138
TABLE 116 GERMANY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 138
TABLE 117 GERMANY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 139
9.4.3 FRANCE 139
9.4.3.1 Strong focus on research and innovation of diagnostic devices to drive growth 139
TABLE 118 FRANCE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 139
TABLE 119 FRANCE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 120 FRANCE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 140
TABLE 121 FRANCE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 141
TABLE 122 FRANCE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 141
TABLE 123 FRANCE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142
TABLE 124 FRANCE: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 142

9.4.4 UK 142
9.4.4.1 Increasing accessibility of IVD devices to drive growth 142
TABLE 125 UK: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 143
TABLE 126 UK: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 127 UK: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 143
TABLE 128 UK: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 144
TABLE 129 UK: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 144
TABLE 130 UK: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145
TABLE 131 UK: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 145
9.4.5 ITALY 145
9.4.5.1 Lack of supporting infrastructure to restrain growth 145
TABLE 132 ITALY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 146
TABLE 133 ITALY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 134 ITALY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 146
TABLE 135 ITALY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 147
TABLE 136 ITALY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 147
TABLE 137 ITALY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148
TABLE 138 ITALY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 148
9.4.6 SPAIN 148
9.4.6.1 Increasing demand for diagnostic equipment to boost demand for contract manufacturing 148
TABLE 139 SPAIN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 149
TABLE 140 SPAIN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 141 SPAIN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 149
TABLE 142 SPAIN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 150
TABLE 143 SPAIN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 150
TABLE 144 SPAIN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 151
TABLE 145 SPAIN: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 151
9.4.7 REST OF EUROPE 151
TABLE 146 REST OF EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 152
TABLE 147 REST OF EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 148 REST OF EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 152
TABLE 149 REST OF EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 153
TABLE 150 REST OF EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 153
TABLE 151 REST OF EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 154
TABLE 152 REST OF EUROPE: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 154
9.5 REST OF THE WORLD 154
9.5.1 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION 155
9.5.2 MIDDLE EAST & AFRICA: IMPACT OF ECONOMIC RECESSION 155
TABLE 153 REST OF THE WORLD: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021–2028 (USD MILLION) 155
TABLE 154 REST OF THE WORLD: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 155 REST OF THE WORLD: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021–2028 (USD MILLION) 156
TABLE 156 REST OF THE WORLD: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021–2028 (USD MILLION) 157
TABLE 157 REST OF THE WORLD: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 157
TABLE 158 REST OF THE WORLD: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 158
TABLE 159 REST OF THE WORLD: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021–2028 (USD MILLION) 158
10 COMPETITIVE LANDSCAPE 159
10.1 OVERVIEW 159
10.2 STRATEGIES OF KEY PLAYERS/RIGHT TO WIN 159
10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY DIAGNOSTIC CONTRACT MANUFACTURERS 159
10.3 REVENUE ANALYSIS 160
FIGURE 24 REVENUE ANALYSIS OF KEY PLAYERS 160
10.4 MARKET SHARE ANALYSIS 161
FIGURE 25 IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET: DEGREE OF COMPETITION 161
FIGURE 26 DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET: DEGREE OF COMPETITION 162

10.5 COMPANY EVALUATION MATRIX 163
10.5.1 STARS 163
10.5.2 EMERGING LEADERS 163
10.5.3 PERVASIVE PLAYERS 163
10.5.4 PARTICIPANTS 163
FIGURE 27 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (2022) 164
10.6 FOOTPRINT ANALYSIS OF COMPANIES 165
TABLE 160 OVERALL FOOTPRINT OF COMPANIES 165
TABLE 161 DEVICE TYPE FOOTPRINT OF COMPANIES 166
TABLE 162 REGIONAL FOOTPRINT OF COMPANIES 167
10.7 COMPETITIVE BENCHMARKING 168
TABLE 163 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: LIST OF KEY START-UP/SME PLAYERS 168
10.8 COMPETITIVE SCENARIO 169
10.8.1 PRODUCT/SERVICE LAUNCHES AND APPROVALS 169
TABLE 164 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: PRODUCT/SERVICE LAUNCHES AND APPROVALS, 2020–2023 169
10.8.2 DEALS 170
TABLE 165 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: DEALS, 2020–2023 170
10.8.3 OTHER DEVELOPMENTS 171
TABLE 166 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: OTHER DEVELOPMENTS, 2020–2023 171
11 COMPANY PROFILES 172
(Business overview, Products/Services/Solutions offered, Recent Developments, MNM view)*
11.1 KEY PLAYERS 172
11.1.1 JABIL INC. 172
TABLE 167 JABIL INC.: COMPANY OVERVIEW 172
FIGURE 28 JABIL INC.: COMPANY SNAPSHOT (2022) 173
11.1.2 FLEX LTD. 176
TABLE 168 FLEX LTD.: COMPANY OVERVIEW 176
FIGURE 29 FLEX LTD.: COMPANY SNAPSHOT (2022) 176
11.1.3 PLEXUS CORP. 178
TABLE 169 PLEXUS CORP.: COMPANY OVERVIEW 178
FIGURE 30 PLEXUS CORP.: COMPANY SNAPSHOT (2022) 179
11.1.4 SANMINA CORPORATION 181
TABLE 170 SANMINA CORPORATION: COMPANY OVERVIEW 181
FIGURE 31 SANMINA CORPORATION: COMPANY SNAPSHOT (2022) 182
11.1.5 TE CONNECTIVITY LTD. 185
TABLE 171 TE CONNECTIVITY LTD.: COMPANY OVERVIEW 185
FIGURE 32 TE CONNECTIVITY LTD.: COMPANY SNAPSHOT (2022) 186

11.1.6 CELESTICA INC. 188
TABLE 172 CELESTICA INC.: COMPANY OVERVIEW 188
FIGURE 33 CELESTICA INC.: COMPANY SNAPSHOT (2022) 188
11.1.7 INTEGER HOLDINGS CORPORATION 190
TABLE 173 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW 190
FIGURE 34 INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022) 190
11.1.8 NIPRO CORPORATION 192
TABLE 174 NIPRO CORPORATION: COMPANY OVERVIEW 192
FIGURE 35 NIPRO CORPORATION: COMPANY SNAPSHOT (2022) 193
11.1.9 THERMO FISHER SCIENTIFIC 195
TABLE 175 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW 195
FIGURE 36 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022) 196
11.1.10 WEST PHARMACEUTICAL SERVICES, INC. 198
TABLE 176 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW 198
FIGURE 37 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2022) 199
11.1.11 BENCHMARK ELECTRONICS INC. 200
TABLE 177 BENCHMARK ELECTRONICS INC.: COMPANY OVERVIEW 200
FIGURE 38 BENCHMARK ELECTRONICS INC.: COMPANY SNAPSHOT (2022) 201
11.1.12 KIMBALL ELECTRONICS INC. 203
TABLE 178 KIMBALL ELECTRONICS INC.: COMPANY OVERVIEW 203
FIGURE 39 KIMBALL ELECTRONICS INC.: COMPANY SNAPSHOT (2022) 204
11.1.13 KMC SYSTEMS 206
TABLE 179 KMC SYSTEMS: COMPANY OVERVIEW 206
11.1.14 SAVYON DIAGNOSTICS 208
TABLE 180 SAVYON DIAGNOSTICS: COMPANY OVERVIEW 208
11.1.15 NOVA BIOMEDICAL 209
TABLE 181 NOVA BIOMEDICAL: COMPANY OVERVIEW 209
11.2 OTHER PLAYERS 211
11.2.1 CENOGENICS CORPORATION 211
11.2.2 CONE BIOPRODUCTS 211
11.2.3 AVIOQ, INC. 212
11.2.4 PHILLIPS-MEDISIZE CORPORATION 213
11.2.5 INVETECH 214
11.2.6 MERIDIAN BIOSCIENCE, INC. 214
11.2.7 NOLATO AB 216
11.2.8 FUJIREBIO 217
11.2.9 SEKISUI 218
11.2.10 PRESTIGE DIAGNOSTICS 218
11.2.11 BIOKIT 219
*Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.

12 APPENDIX 220
12.1 DISCUSSION GUIDE 220
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 224
12.3 CUSTOMIZATION OPTIONS 226
12.4 RELATED REPORTS 226
12.5 AUTHOR DETAILS 227